![[Communiqué de Presse] Lancement de l’Alliance Promotion Microbiote](https://www.biofortis.fr/wp-content/uploads/2021/04/Lancement-de-lAlliance-Promotion-Microbiote-2-LINKEDIN.png)
by Administrateur Biofortis | Apr 7, 2021 | News
Lancement de l’Alliance Promotion Microbiote Le 29 mars 2021 – L’Alliance Promotion Microbiote est lancée : fruit de l’union d’une quinzaine d’acteurs publics et privés engagés (instituts de recherche, entreprises, pôles de compétitivité), elle vise à promouvoir...
![[POSTER] What about Nasal Microbiota?](https://www.biofortis.fr/wp-content/uploads/2021/03/VignetteNasalMicrobiota_Biofortis-1080x675.jpg)
by Administrateur Biofortis | Mar 15, 2021 | Microbiome
Morgane Pierre, Sophie Le Fresne-Languille & Thomas Carton, Biofortis The nasal cavity is a highly complex air-filled space with several distinct zones. As the first part of therespiratory tract and because of its connexions with other body compartments, its...
by Administrateur Biofortis | Dec 17, 2020 | Webinar
Exploring the microbiome: Part 2// Bioinformatics and Data Sciences : From raw data to conclusions Many nutritional or drug intervention strategies can modulate the microbiome. This topic highlighting the microbiome analysis will be splitted in two different...
by Administrateur Biofortis | Oct 8, 2020 | Webinar
PART I // Microbiome: new efficacy and toxicity endpoint in clinical study Webinar presented by: – SPEAKER: Françoise Le Vacon: Chief Scientific Officer – MODERATOR: Stéphane Deniau: Business Manager Exploring the microbiome: from sample to data analysis...
by Administrateur Biofortis | Apr 21, 2020 | Health, Microbiome
For April’s Autism Awareness month, we wanted to return to the role of our gut bacteria in this neurodevelopmental disorder. Autism is not a psychiatric/psychological disease. It is a pervasive neurodevelopmental disorder characterized by a dyad of impairing signs...
